ArticleTrials2025

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.

Linda J Harrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.